This Monday, there was a pivotal ruling from the U.S., which carries significant implications for the pharmaceutical industry and healthcare costs. 🔍 Case Summary: The court rejected a legal ...
A federal judge has dismissed legal challenges to the Medicare negotiation program brought by Bristol Myers Squibb and Johnson & Johnson, ruling that their claims of unconstitutionality are unfounded.
Explore stories from Atlantic Canada. Third teenager charged with second-degree murder | SaltWire #newsupdate #news #halifax #police - A U.S. judge on Monday rejected a challenge by Bristol Myers ...
Bristol Myers Squibb’s products Eliquis and Farxiga were both named among the first 10 drugs eligible for Medicare negotiation, as were Xarelto, Imbruvica and Stelara from Johnson & Johnson. The ...
The multiple myeloma market is booming. Bloomberg Intelligence (BI) forecasts sales will hit $33 billion in 2030, up almost ...
Sifting through countless of stocks in the Pharmaceuticals industry can be tedious, and sometimes two stocks are just too similar to judge which is the better investment. If you’re on the fence about ...
S&P 500 operating EPS growth was solid at 6.4% in Q1, but critics argue that excluding profits from top tech stocks shows less impressive growth. Bristol-Myers Squibb faces a soft growth outlook ...
- A US district court judge has found Bristol-Myers Squibb's patent on the use of Buspar (buspirone), used in the treatment of neurotic anxiety, to be invalid. Bristol-Myers and its Mead Johnson unit ...
Expenses related to acquisitions recently weighed down Bristol Myers' earnings results. The company, however, still generates strong free cash flow. Its high debt load could turn off some risk ...
Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products ...
As of May 31, 2024, Johnson & Johnson had a $349.6 billion market capitalization, putting it in the 100th percentile of companies in the Pharmaceuticals industry. Currently, Johnson & Johnson’s ...
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for hematology, oncology ...